share_log

巨子生物增资至6.9亿 增幅约110%

Juzi Biology has increased its capital to 0.69 billion, an increase of approximately 110%.

Breakings ·  Dec 19 15:02

According to the Tianyancha App, recently, Juzi Biology (HK.02367) underwent an industrial and commercial change, with registered capital increased from approximately 0.33 billion RMB to approximately 0.69 billion RMB, an increase of about 110%. Xi'an Juzi Biology Genetic Technologies Co., Ltd. was established in September 2001, with Yan Jianya as the legal representative. The scope of operation includes the production of class I medical instruments, manufacturing of biological base materials, production of daily chemical products, manufacturing of chemical products, sales of class I medical instruments, sales of class II medical instruments, sales of sanitary products, and sales of disposable medical supplies, currently jointly held by Fan Daidi, Guangdong Jinli Investment Co., Ltd., and Zhongrun Economic Development Co., Ltd.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment